Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Albert Einstein College of Medicine · Montefiore Medical Center
Abstract
Abstract Patients with cancer are presumed to be at increased risk from COVID-19 infection–related fatality due to underlying malignancy, treatment-related immunosuppression, or increased comorbidities. A total of 218 COVID-19–positive patients from March 18, 2020, to April 8, 2020, with a malignant diagnosis were identified. A total of 61 (28%) patients with cancer died from COVID-19 with a case fatality rate (CFR) of 37% (20/54) for hematologic malignancies and 25% (41/164) for solid malignancies. Six of 11 (55%) patients with lung cancer died from COVID-19 disease. Increased mortality was significantly associated with older age, multiple comorbidities, need for ICU support, and elevated levels of D-dimer,…
Citation impact
- FWCI
- 62.37
- Percentile
- 100%
- References
- 13
Authors
19- VMVikas MehtaCorresponding
Albert Einstein College of Medicine
- SGSanjay Goel
Albert Einstein College of Medicine, Montefiore Medical Center
- RKRafi Kabarriti
Albert Einstein College of Medicine, Montefiore Medical Center
- DJDaniel J. Cole
Albert Einstein College of Medicine, Montefiore Medical Center
- MGMendel Goldfinger
Albert Einstein College of Medicine, Montefiore Medical Center
Topics & keywords
- Case fatality rate
- Coronavirus disease 2019 (COVID-19)
- Cancer
- 2019-20 coronavirus outbreak
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
- Medicine
- Virology
- Intensive care medicine
- Good health and well-being